AZD 6942

Drug Profile

AZD 6942

Alternative Names: CCR2b

Latest Information Update: 03 Dec 2001

Price : $50

At a glance

  • Originator AstraZeneca
  • Class Antirheumatics
  • Mechanism of Action CCR2 receptor antagonists; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Rheumatoid arthritis

Most Recent Events

  • 03 Dec 2001 Discontinued - Clinical-Phase-Unknown for Rheumatoid arthritis in Sweden (unspecified route)
  • 20 Sep 2001 New profile
  • 20 Sep 2001 Investigation in Rheumatoid arthritis in Sweden (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top